Drug Information: A Guide for Pharmacists, 5e

Patrick M. Malone, PharmD, FASHP, Karen L. Kier, PhD, MSc, RPh, BCPS, BCACP, John E. Stanovich, RPh, Meghan J. Malone, PharmD, BCPS, CACP

Go to Review Questions

• Chapter 1: Introduction to the Concept of Drug Information
• Chapter 2: Formulating Effective Responses and Recommendations: A Structured Approach
• Chapter 3: Drug Information Resources
• Chapter 4: Drug Literature Evaluation I: Controlled Clinical Trial Evaluation
• Chapter 5: Literature Evaluation II: Beyond the Basics
• Chapter 6: Pharmacoeconomics
• Chapter 7: Evidence-Based Clinical Practice Guidelines
• Chapter 8: The Application of Statistical Analysis in the Biomedical Sciences
• Chapter 9: Professional Writing
• Chapter 10: Legal Aspects of Drug Information Practice
• Chapter 11: Ethical Aspects of Drug Information Practice
• Chapter 12: Pharmacy and Therapeutics Committee
• Chapter 13: Drug Evaluation Monographs
• Chapter 14: Quality Improvement and the Medication Use System
• Chapter 15: Medication Misadventures I: Adverse Drug Reactions
• Chapter 16: Medication Misadventures II: Medication and Patient Safety
• Chapter 17: Investigational Drugs
• Chapter 18: Policy Development, Project Design, and Implementation
• Chapter 19: Drug Information in Ambulatory Care
• Chapter 20: Drug Information and Contemporary Community Pharmacy Practice
• Chapter 21: Drug Information Education and Training
• Chapter 22: Pharmaceutical Industry and Regulatory Agency Drug Information
• Chapter 23: Assessing Drug Promotions
• Chapter 24: Pharmacy Informatics: Enabling Safe and Efficacious Medication Use
• Glossary
• Answers for Case Studies
• Appendices